You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

Displaying 1 - 10 of 4751 results
  1. ZombieCam: Machine Learning common-sense anomaly detection for defense applications

    SBC: CHIRAL SOFTWARE, INC.            Topic: AF183002

    ZombieCam software and technology, and the SERA anomaly detection algorithm, developed by Chiral Software in the course of our research for DARPA and Lockheed Martin, learns to detect anomalies in images and other data sets. Learning is based on common sense and observed context, not pre-defined rules. Video streams are understood for objects out of place, out of time, or otherwise unexpected. We ...

    SBIR Phase I 2019 Department of DefenseAir Force
  2. ZettaViz: Visual Analysis Workflows for Data Resources in the Cloud

    SBC: KITENGA CO.            Topic: OSD09SP1

    The future of information analysis in the orbital, air, ground, sea and undersea battlespace is a future characterized by massive information streams and data overload. Existing tools and capabilities are also incapable of handling the huge bandwidth and analysis needs of semi-structured, unstructured (text) and geo-spatial information resources. Kitenga Co., as part of our ZettaVox cloud and cl ...

    SBIR Phase I 2010 Department of DefenseArmy
  3. Zero-stage Operationally Range-independent Gantry (ZORG)

    SBC: Exquadrum, Inc.            Topic: MDA18022

    During the proposed Phase I research and development effort, the project team will conduct a study to identify and document Missile Defense Agency’s requirements for an innovative air, sea, and ground-mobile launch platform solution that would reduce fielding infrastructure costs and is capable of launching all target missile systems. The project team will design an operationally safe, reliable, ...

    SBIR Phase I 2019 Department of DefenseMissile Defense Agency
  4. Zero Leakage Rotary Union for Gaseous Cryogen Transport

    SBC: MAINSTREAM ENGINEERING CORPORATION            Topic: N101063

    Advances in naval weapon and propulsion technology are requiring large increases in power production. New technologies to meet these greater power demands has lead to advanced high speed, high power density electrical generators on-board naval vessels, which require active cooling of generator components. A significant problem experienced in the use of new generator technology is the transport of ...

    SBIR Phase I 2010 Department of DefenseNavy
  5. Yield Improvement for Miniature Cameras

    SBC: Five Focal LLC            Topic: NM

    This Small Business Innovation Research (SBIR) Phase I project will address the technical barrier of manufacturing error identification which fundamentally limits the achievable yields in the production of miniature cameras. The methods employed in miniature camera manufacturing severely limit access to metrology data at the component-level. Adequate characterization data is only obtained in out-g ...

    SBIR Phase I 2010 National Science Foundation
  6. Y2 and Y4 Agonists in Obesity

    SBC: P2D, INC            Topic: NIDDK

    DESCRIPTION (provided by applicant): The purpose of the proposed studies is to assess the feasibility of developing a novel Neuropeptide Y (NPY) obesity treatment. Extensive preclinical and clinical studies indicate that NPY receptors are important mediators of appetite and obesity. The proposed Specific Aims will determine if chronic treatment with selective NPY Y2 or Y4 receptor agonists demonst ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. XT-101: A Potent IL-10 Based Therapy for Treating Multiple Sclerosis.

    SBC: XALUD THERAPEUTICS, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): Xalud Therapeutics proposes to evaluate the applicability of its novel and potent anti-inflammatory therapy, XT-101, for the treatment of motor impairment, gait disorders, and neuropathic pain in degenerative and inflammatory autoimmune rodent models of multiple sclerosis (MS). XT-101 is a non-viral form of gene therapy that causes the meningeal cells surround ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. X-ray Detection and Processing Models for Spacecraft Navigation and Timing

    SBC: Microcosm, Inc.            Topic: O402

    Based on work done under Microcosm's recently completed Phase II SBIR program on X-ray pulsar based navigation (XNAV), relevant X-ray source characterization, X-ray detector measurement models, and source timing models will be developed to support eventual implementation in the GEONS flight software environment. In Phase I, an initial assessment will be made of the key model parameters and accura ...

    SBIR Phase I 2010 National Aeronautics and Space Administration
  9. Wrapped-IMLI: Thermal Insulation for Cryogenic Feed Lines

    SBC: Quest Product Development Corporation            Topic: X801

    NASA Exploration vehicles require improved technologies for passive thermal insulation for zero boil-off of cryopropellants during extended LEO and lunar surface missions. Vehicles such as the Earth Departure Stage and Orion must be capable of multi-day orbital operation with minimal cryopropellant loss, and the Altair Lunar Lander must have minimal cryopropellant loss over a six month mission on ...

    SBIR Phase I 2010 National Aeronautics and Space Administration
  10. Wound Decontamination for the Prevention and Treatment of Multi-drug Resistant Ba

    SBC: SYNEDGEN, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The frequency of multi-drug resistant infections is increasing at an alarming rate. Equally concerning is the limited therapeutic options available for effective treatment, resulting in increased morbidity and mortality associated with these highly resistant infections. Frequently, multi-drug resistant infections manifest as soft tissue or wound infections caus ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government